GGrantIndex
Sort

82,697 grants matching vaccine development

Coxiella burnetii immunobiology, host-pathogen modeling, and countermeasure development

$880,868
Carrie Mae Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI

Designing HIV-1 envelope immunogens to maximize neutralization breadth through use of multiple founder envelope antigens

$880,838
Sandhya Vasan · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2024 · AI

Biology and Therapy of Lymphopenia

$880,808
Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

Targeting PD-1 Pathway for Functional Cure of AIDS

$880,613
Rama Rao Amara · Emory University · R01 · FY2025 · AI

Discovery of Molecules to disrupt the outer membrane of Gram-negative pathogens

$880,606
Daniel E Kahne · Harvard Medical School · U19 · FY2017 · AI

Immunoprevention and immunosurveillance of human non-viral cancers

$880,514
Olivera J Finn · University Of Pittsburgh At Pittsburgh · R35 · FY2020 · CA

Novel DNA Repair Inhibitors for Cancer Therapy

$880,502
Peter M Glazer · Yale University · R35 · FY2019 · CA

Optimizing glycan shield coverage, germline B cell receptor binding and epitope diversity of V2-apex targeted HIV-1 Env immunogens

$880,342
Beatrice H Hahn · University Of Pennsylvania · R37 · FY2019 · AI

Viral Respiratory Pathogens Research Unit

$880,288
Robert B Couch · Baylor College Of Medicine · N01 · FY2012 · AI

Strategies for Prevention of Autoimmunity

$880,068
Stanford University · U19 · FY2002 · DK

TOWARDS A MORE RELEVANT MODEL OF HIV INFECTION

$880,000
Julie M Overbaugh · Fred Hutchinson Cancer Research Center · DP1 · FY2015 · DA

TOWARDS A MORE RELEVANT MODEL OF HIV INFECTION

$880,000
Julie M Overbaugh · Fred Hutchinson Cancer Research Center · DP1 · FY2018 · DA

CAREER: Selective sweep of plasma cell specificity following vaccination

$880,000
Erin Bromage · University Of Massachusetts, Dartmouth · · FY2012 · BIO

TOWARDS A MORE RELEVANT MODEL OF HIV INFECTION

$880,000
Julie M Overbaugh · Fred Hutchinson Cancer Research Center · DP1 · FY2019 · DA

TOWARDS A MORE RELEVANT MODEL OF HIV INFECTION

$880,000
Julie M Overbaugh · Fred Hutchinson Cancer Research Center · DP1 · FY2017 · DA

NIAID- VRC - PREMISE - Pandemic Response Repository through Microbial and Immunologic Surveillance and Epidemiology

$880,000
Christopher Case · Leidos Biomedical Research, Inc. · N01 · FY2022 · AI

HIV-1 Fusion Peptide-directed Vaccine Design Using Virus-like Particles

$879,691
Rui Kong · Emory University · R01 · FY2025 · AI

Population genotyping of the germline immunoglobulin repertoire in AIDS-designated rhesus macaque breeding colonies

$879,617
Steven Edward Bosinger · Emory University · R24 · FY2025 · AI

Endolysins as tools to eradicate pneumococcal biofilms and development ofprotective immunity

$879,588
Norberto Gonzalez-Juarbe · Univ Of Maryland, College Park · R01 · FY2025 · AI

Improving Quality of Care for the Treatment of Childhood Pneumonia

$879,558
Patricia L Hibberd · Massachusetts General Hospital · U01 · FY2012 · HD

Mechanisms of effective antibody neutralization of malaria parasites

$879,554
Niraj Tolia · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

Discovery of Molecules to disrupt the outer membrane of Gram-negative pathogens

$879,530
Daniel E Kahne · Harvard Medical School · U19 · FY2015 · AI

Targeting bacterial cell wall biogenesis for the development of novel antimicrob

$879,508
Thomas G Bernhardt · Harvard Medical School · U19 · FY2014 · AI

Advancing a Glioma Immunotherapy

$879,408
Dwaine Franklin Emerich · In Cytu, Inc. · R44 · FY2016 · NS

CENTER FOR RECOMBINANT GAMETE CONTRACEPTIVE VACCINOGENS

$879,398
University Of Virginia Charlottesville · U54 · FY2002 · HD